| Tag | Content |
|---|
EnhancerAtlas ID | HS157-05347 |
Organism | Homo sapiens |
Tissue/cell | PANC-1 |
Coordinate | chr16:28935020-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GAATTTTAGG AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG 60
TGAGAAGGTT GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC 120
ATAGCAGCGG GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG 180
AGAGTAGAAA ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA 240
CGTGGGGCGG AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG 300
AAGGCTAGAG AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC 360
AGAAGTCCAG ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA 420
GGGTTGATCA ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG 480
CTGGGAGCTA AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT 540
GCAAATTTTA AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC 600
CTGCTAACCT ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC 660
AGTATGGGGT TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 700
|
